Pfizer debt and dilution18

Borrowings, liquidity, share count and stock-based dilution.

Total debt

USD millions

$63,194M

Cash & equivalents

USD millions

$976M

Net debt

USD millions

$62,218M

Debt / equity

0.74×

Debt / assets

31.42%

Net debt / EBITDA

× · TTM

—

Operating income is unavailable in the extracted statements for this period.

Debt / FCF

× · TTM

5.75×

Interest coverage

× · TTM

—

Operating income is unavailable in the extracted statements for this period.

Current ratio

1.27×

Diluted shares

Million shares

5,699M shares

Basic shares

Million shares

5,699M shares

Share count growth

0.25%

Share repurchases

USD millions

—

Quarterly data

Pfizer capital history. Each metric has its own unit. A dash means inputs are missing or the calculation is undefined.
Fiscal period	Ended	Total debtUSD millions	Cash & equivalentsUSD millions	Net debtUSD millions	Debt / equity×	Debt / assets%	Net debt / EBITDA×	Debt / FCF×	Interest coverage×	Current ratio×	Diluted sharesMillion shares	Basic sharesMillion shares	Share count growth%	Share repurchasesUSD millions
FY 2026 Q2	Jun 28, 2026	63,194	976	62,218	0.74×	31.42%	—	5.75×	—	1.27×	5,699	5,699	0.25%	—
FY 2026 Q1	Mar 29, 2026	64,455	1,703	62,752	0.71×	31.04%	—	6.8×	—	1.25×	5,731	5,691	0.28%	—
FY 2025 Q4	Dec 31, 2025	64,795	1,142	63,653	0.75×	31.13%	—	7.14×	—	1.16×	5,721.65	5,685.88	0.33%	—
FY 2025 Q3	Sep 28, 2025	61,712	1,343	60,369	0.66×	29.57%	—	5.95×	—	1.28×	5,714	5,685	0.32%	—
FY 2025 Q2	Jun 29, 2025	61,797	1,638	60,159	0.69×	29.98%	—	4.97×	—	1.16×	5,706	5,685	0.34%	—
FY 2025 Q1	Mar 30, 2025	62,109	1,430	60,679	0.69×	29.86%	—	5.54×	—	1.26×	5,710	5,675	0.32%	—
FY 2024 Q4	Dec 31, 2024	64,351	1,043	63,308	0.73×	30.16%	—	6.54×	—	1.17×	5,702.94	5,666.94	0.37%	—
FY 2024 Q3	Sep 29, 2024	67,701	1,092	66,609	0.73×	30.85%	—	8.23×	—	1×	5,705	5,667	0.37%	—
FY 2024 Q2	Jun 30, 2024	69,450	1,052	68,398	0.79×	32.12%	—	14.44×	—	0.86×	5,696	5,666	0.35%	—
FY 2024 Q1	Mar 31, 2024	69,539	719	68,820	0.75×	31.45%	—	13.62×	—	1.05×	5,697	5,657	0.41%	—
FY 2023 Q4	Dec 31, 2023	71,888	2,853	69,035	0.81×	31.74%	—	15×	—	0.91×	5,693.95	5,646.01	0.57%	0
FY 2023 Q3	Oct 1, 2023	63,596	3,148	60,448	0.65×	29.58%	—	7.78×	—	2.38×	5,646	5,646	0.7%	0
FY 2023 Q2	Jul 2, 2023	65,341	2,632	62,709	0.66×	29.68%	—	6.13×	—	2.12×	5,713	5,646	0.95%	0
FY 2023 Q1	Apr 2, 2023	35,892	2,166	33,726	0.35×	18.35%	—	1.78×	—	1.37×	5,727	5,634	0.3%	0
FY 2022 Q4	Dec 31, 2022	35,829	416	35,413	0.37×	18.17%	—	1.38×	—	1.22×	5,745.22	5,614.11	0.01%	0
FY 2022 Q3	Oct 2, 2022	36,669	1,298	35,371	0.39×	18.77%	—	1.57×	—	1.59×	5,718	5,607	-0.04%	0
FY 2022 Q2	Jul 3, 2022	40,284	1,780	38,504	0.46×	20.63%	—	1.42×	—	1.42×	5,712	5,593	-0.09%	0
FY 2022 Q1	Apr 3, 2022	36,301	2,470	33,831	0.44×	19.75%	—	1.14×	—	1.39×	5,758	5,617	0.59%	2,000
FY 2021 Q4	Dec 31, 2021	38,436	1,944	36,492	0.5×	21.18%	—	1.29×	—	1.4×	5,770.02	5,613.4	19.22%	0
FY 2021 Q3	Oct 3, 2021	39,879	1,966	37,913	0.52×	22.26%	—	1.34×	—	1.39×	5,725	5,609	-4.24%	0
FY 2021 Q2	Jul 4, 2021	39,242	2,372	36,870	0.56×	23.09%	—	1.86×	—	1.37×	5,678	5,598	-4.37%	0
FY 2021 Q1	Apr 4, 2021	39,699	1,768	37,931	0.58×	25%	—	2.95×	—	1.48×	5,662	5,584	-4.46%	0
FY 2020 Q4	Dec 31, 2020	39,836	1,784	38,052	0.63×	25.83%	—	3.28×	—	1.35×	4,794.5	4,708.32	-19.28%	0
FY 2020 Q3	Sep 27, 2020	63,148	1,587	61,561	0.96×	35.28%	—	6.07×	—	1.4×	5,937.18	5,857.08	0.22%	0
FY 2020 Q2	Jun 28, 2020	63,613	1,801	61,812	0.99×	35.75%	—	4.97×	—	1.42×	5,922.43	5,853.92	-0.14%	0
FY 2020 Q1	Mar 29, 2020	52,288	2,151	50,137	0.8×	31.44%	—	4.41×	—	1.03×	5,916.1	5,844.43	-1.6%	0
FY 2019 Q4	Dec 31, 2019	52,150	1,305	50,845	0.82×	31.14%	—	5.01×	—	0.88×	5,935.21	5,832.73	-4.45%	0
FY 2019 Q3	Sep 29, 2019	52,661	2,785	49,876	0.81×	30.9%	—	4.63×	—	0.9×	5,954.05	5,844.43	-5.62%	0
FY 2019 Q2	Jun 30, 2019	46,675	1,784	44,891	0.78×	29.88%	—	3.85×	—	1.47×	5,978.29	5,862.35	-5.18%	0
FY 2019 Q1	Mar 31, 2019	45,143	1,937	43,206	0.76×	29.05%	—	3.36×	—	1.54×	6,060.5	5,939.29	—	8,865
FY 2018 Q4	Dec 31, 2018	41,740	1,139	40,601	0.65×	26.18%	—	3.03×	—	1.57×	6,234.08	6,104.64	—	5,030
FY 2018 Q3	Sep 30, 2018	41,037	3,559	37,478	0.57×	24.45%	—	—	—	1.43×	6,309.24	6,192.25	—	1,105
FY 2018 Q2	Jul 1, 2018	40,518	2,704	37,814	0.58×	24.56%	—	—	—	1.16×	6,273.41	6,182.76	—	0
FY 2014 Q2	Jun 29, 2014	37,828	3,406	34,422	0.49×	21.92%	—	2.17×	—	2.66×	6,791.98	6,711.87	-9.57%	1,323
FY 2014 Q1	Mar 30, 2014	36,968	2,862	34,106	0.47×	21.52%	—	2.15×	—	2.33×	6,825.7	6,734.01	-11.1%	1,197
FY 2013 Q4	Dec 31, 2013	36,489	2,183	34,306	0.48×	21.2%	—	2.2×	—	2.41×	6,894.33	6,795.57	-11.92%	4,647
FY 2013 Q3	Sep 29, 2013	36,550	2,052	34,498	0.47×	20.82%	—	2.29×	—	2.92×	7,015.42	6,936.37	-11.5%	3,754
FY 2013 Q2	Jun 30, 2013	36,746	2,436	34,310	0.47×	20.49%	—	2.44×	—	2.62×	7,501.32	7,422.27	-5.81%	3,263
FY 2013 Q1	Mar 31, 2013	40,377	2,134	38,243	0.49×	21.55%	—	2.65×	—	2.35×	7,661.53	7,575.1	-4.64%	4,626
FY 2012 Q4	Dec 31, 2012	37,460	10,389	27,071	0.46×	20.16%	—	2.38×	—	2.15×	7,781.59	7,715.17	-4.11%	3,394
FY 2012 Q3	Sep 30, 2012	38,857	4,506	34,351	0.47×	21.28%	—	2.49×	—	1.96×	7,913.43	7,837.54	-4.3%	1,835
FY 2012 Q2	Jul 1, 2012	38,571	3,031	35,540	0.48×	21.1%	—	2.59×	—	1.91×	7,944	7,879.7	-5.07%	1,340
FY 2012 Q1	Apr 1, 2012	39,069	2,934	36,135	0.47×	21.04%	—	2.34×	—	2.02×	8,008.29	7,944	-5.58%	1,659
FY 2011 Q4	Dec 31, 2011	38,949	3,539	35,410	0.47×	20.72%	—	2.1×	—	2.06×	8,117.85	8,045.88	-4.68%	3,211
FY 2011 Q3	Oct 2, 2011	41,036	3,706	37,330	0.45×	20.92%	—	2.09×	—	2.25×	8,231.74	8,189.58	-3.2%	2,110
FY 2011 Q2	Jul 3, 2011	41,711	3,096	38,615	0.47×	21.29%	—	1.89×	—	1.98×	8,363.49	8,300.25	-2.13%	2,249
FY 2011 Q1	Apr 3, 2011	41,401	730	40,671	0.46×	21.24%	—	1.97×	—	2×	8,468.89	8,413.03	-0.98%	1,430
FY 2010 Q4	Dec 31, 2010	44,033	1,735	42,298	0.5×	22.58%	—	4.43×	—	2.11×	8,493.65	8,440.53	2.63%	0
FY 2010 Q3	Oct 3, 2010	44,168	2,176	41,992	0.5×	23.07%	—	5.12×	—	2.24×	8,492.08	8,460.46	19.27%	500
FY 2010 Q2	Jul 4, 2010	43,274	1,877	41,397	0.5×	22.65%	—	7.12×	—	2.07×	8,507.89	8,480.48	19.59%	—
FY 2010 Q1	Apr 4, 2010	46,050	1,759	44,291	0.51×	23.6%	—	7.91×	—	1.93×	8,538.45	8,496.29	—	—
FY 2009 Q4	Dec 31, 2009	48,662	1,978	46,684	0.54×	22.85%	—	3.16×	—	1.66×	8,285.16	8,224.14	—	0
FY 2009 Q3	Sep 27, 2009	39,356	4,234	35,122	0.59×	27.85%	—	—	—	3.08×	7,127.15	7,093.42	—	0
FY 2009 Q2	Jun 28, 2009	39,509	2,244	37,265	0.62×	28.35%	—	—	—	2.74×	7,116.61	7,091.31	—	—

Sources and calculations

Financial inputs from company filings. Last checked Oct 18, 2026. A dash means missing inputs or an undefined calculation.

Period changes use the preceding fiscal quarter or year. Percentage changes divide by the absolute prior value; a zero or missing baseline has no percentage change. Percentage metrics show changes in percentage points.

The SBC option subtracts reported share-based compensation from FCF as an economic-cost scenario. Missing SBC never becomes zero.

Debt uses reported borrowings, with overlapping concepts treated as alternatives. Cash excludes restricted cash and short-term investments. Dilution compares split-normalized weighted average basic shares year over year. Share buyback spending does not by itself measure shares retired.

Market prices: Yahoo Finance · PFE, USD. Latest completed close Sep 25, 2026. Price data retrieved Sep 28, 2026.

Total debt: Reported borrowing balances. Uses an aggregate including current maturities, or current plus noncurrent debt. Adds separately disclosed short-term borrowings, with commercial paper as a fallback, unless the selected current/aggregate concept already includes them. Finance leases are included when part of the reported debt concept; undisclosed components are not estimated.
Cash & equivalents: Unrestricted reported cash and cash equivalents. Excludes short-term investments and restricted cash.
Net debt: Total debt − cash and equivalents. Negative means net cash.
Debt / equity: Total debt / equity including noncontrolling interests. Nonpositive equity yields unavailable.
Debt / assets: Total debt / total assets × 100.
Net debt / EBITDA: Period-end net debt / (TTM operating income + TTM depreciation and amortization). Negative net debt is retained.
Debt / FCF: Period-end reported debt / positive TTM free cash flow. Reflects the selected reported capex scope and SBC option.
Interest coverage: TTM operating income / positive TTM interest expense. IFRS finance costs can include more than interest.
Current ratio: Current assets / positive current liabilities.
Diluted shares: Reported weighted average diluted shares, normalized for subsequent recorded stock splits. Fourth-quarter counts use a day-weighted annual/nine-month reconstruction where possible.
Basic shares: Reported weighted average basic shares, normalized for subsequent recorded stock splits.
Share count growth: Year-over-year change in split-normalized weighted average basic shares × 100. A dilution proxy; negative means a lower share count.
Share repurchases: Reported cash payments for repurchase of common shares. This is spending, not a buyback yield.

SEC company facts · CIK 78003